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Abstract
Objective This retrospective study reports our experience
using splenic arterial particle embolization and coil
embolization for the treatment of sinistral portal hyper-
tension (SPH) in patients with and without gastric bleeding.
Methods From August 2009 to May 2012, 14 patients
with SPH due to pancreatic disease were diagnosed and
treated with splenic arterial embolization. Two different
embolization strategies were applied; either combined
distal splenic bed particle embolization and proximal
splenic artery coil embolization in the same procedure for
acute hemorrhage (1-step) or interval staged distal
embolization and proximal embolization in the stable
patient (2-step). The patients were clinically followed.
Results In 14 patients, splenic arterial embolization was
successful. The one-step method was performed in three
patients suffering from massive gastric bleeding, and the
bleeding was relieved after embolization. The two-step
method was used in 11 patients, who had chronic gastric
variceal bleeding or gastric varices only. The gastric vari-
ces disappeared in the enhanced CT scan and the patients
had no gastric bleeding during follow-up.
Conclusions Splenic arterial embolization, particularly
the two-step method, proved feasible and effective for the
treatment of SPH patients with gastric varices or gastric
variceal bleeding.
Keywords Clinical practice  Interventional
oncology  Arterial intervention  Venous intervention
Introduction
Sinistral (left-sided) portal hypertension (SPH) is charac-
terized by obstruction of the splenic vein leading to isolated
gastric varices, mainly due to pancreatic diseases such as
pancreatitis and pancreatic tumor [1–4]. The consequences
of SPH are potentially fatal.
The direct cause of the occlusion is usually thrombosis
in the splenic vein or compression by masses or cysts.
Blood from the spleen flows towards the stomach via the
short gastric veins and then flows towards the portal vein
[2, 4]. Collateral circulation from the short gastric vein
leads to the dilation of stomach submucosal vessels and
subsequently increased blood flow and venous pressure,
resulting in isolated gastric varices. These isolated gastric
varices are the characteristic clinical feature of SPH, and
may cause life-threatening gastric bleeding [2, 5]. The
incidence of gastric bleeding in SPH varies from 4 to 72 %
[4, 6].
Although the incidence of SPH has increased gradually
in recent decades, there is no consensus on treatment
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splenectomy is an effective treatment for symptomatic or
asymptomatic SPH. Yet, there is controversy regarding
whether splenectomy is necessary for the prevention of
gastrointestinal bleeding in asymptomatic patients [6–9].
Additionally, pancreatitis or the pancreatic tumor may
activate inflammation and cellular adhesion, pancreatitis or
pancreatic malignancy may make a splenectomy more
technically challenging.
Partial splenic embolization with particle embolic
agents has been well accepted for treating hypersplenism
and portal hypertension caused by liver cirrhosis [10].
Moreover, total splenic arterial embolization with coils has
been successfully applied in the treatment of splenic artery
aneurysm [11]. In this retrospective study, we report our
experiences using partial splenic embolization combined
with splenic arterial embolization for the treatment of SPH
patients with or without gastric bleeding.
Methods
Patients
Fourteen patients (12 men and 2 women; 22–59 years) with
the presence of SPH underwent interventional therapy
between August 2009 and May 2012, and were retrospec-
tively analyzed in the present study. The causes of SPH
were chronic pancreatitis in nine patients, acute pancre-
atitis in four patients, and pancreatic tumor in another one
patients. Gastric bleeding occurred in eight patients who
had melena, hematemesis, or both. Five of the eight
patients had a chronic course with melena, and the other
three patients had acute gastric bleeding with melena and
hematemesis. Six asymptomatic patients were diagnosed
during the follow-up of chronic pancreatitis.
Regarding clinical manifestations, ten patients had
symptoms of postprandial fullness. Patients with hepatic
cirrhosis-related portal hypertension were excluded. The
ethics committee approved the study. All of the included
patients provided signed informed consent.
Diagnosis
The diagnosis of SPH was based on the results of CT,
magnetic resonance imaging (MRI), clinical manifestation,
endoscopy, and history. Enhanced CT/MRI provided
detailed images of the liver, pancreas, and spleen, as well
as the morphology of the abdominal vessels such as splenic
arteries, splenic veins, portal veins, and collateral veins.
The gastric varices were confirmed by the endoscopy.
Patients with peptic ulcer were excluded from the current
study.
For the 14 included patients, the splenic vein vanished
completely or partially in the CT/MRI images. Multiple
collateral veins in the splenic hilum were detected in 14
patients. Blood from the spleen drained into the portal
system via the following courses: (1) short gastric vein–
gastric fundal vein–left gastric vein–splenic vein; (2) gas-
troepiploic vein–superior mesenteric vein; (3) short gastric
vein–left gastric vein–splenic vein; (4) gastroepiploic vein–
superior mesenteric vein; and (5) splenic vein–inferior
mesenteric vein–superior mesenteric vein (Fig. 1). One of
the three patients with an affected portal vein had cav-
ernous transformation of the portal vein; the blood drained
into the portal vein via the left gastric vein and the gas-
troepiploic vein. Splenomegaly was confirmed in 14
patients.
Splenic and Splenic Arterial Embolization
Polyvinyl alcohol particles (PVA) (Cook Incorporated,
USA) and coils (Cook Incorporated, USA) were used for
the embolization. All the patients signed consent forms
before the procedure. The patients with acute gastric var-
iceal bleeding were treated with one-step embolization, in
which the spleen and splenic artery were embolized
simultaneously. Firstly, the spleen parenchyma was
embolized with polyvinyl alcohol particles to decrease the
blood flow to the splenic parenchyma and gastric varices.
Then the small-sized coils were placed in the hilar splenic
artery and the larger-sized coils were placed in the proxi-
mal splenic artery.
For the patients with gastric varices or chronic gastric
variceal bleeding, the 2-step embolic method was applied.
Firstly, partial splenic embolization was performed to
achieve infarction of up to 60–70 % of the splenic volume
according the angiography. Partial splenic embolization
reduces the blood flow to the splenic parenchyma and
gastric varices, and therefore the gastric bleeding can be
relieved. The second embolic therapy was performed after
a month with the aforementioned procedures.
Embolization was performed via femoral artery access.
Celiac trunk angiography was performed with a 5-F
Yashiro catheter to detect the splenic artery. Indirect por-
tography was performed to show the images of the splenic
vein, portal vein, and collateral veins. The catheter was
placed in splenic artery near the hilum, and angiography
was performed to show the splenic parenchyma and the
splenic vein, portal vein, and collateral veins. A micro-
catheter was used in a patient with splenic pseudoaneurysm
to pass through the stenosis of the splenic artery caused by
the compression of the pseudoaneurysm. PVA particles
(300–1000 lm) were used to embolize the splenic par-
enchyma. Coils were used to embolize the splenic artery.
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Results
General Results of the Embolization
The embolization was successful in all of the 14 patients.
The 1-step method was performed in three patients (two
patients with acute pancreatitis and one patient with
chronic pancreatitis). The patient with chronic pancreatitis
had splenic arterial pseudoaneurysm, which was embo-
lized with an isolated technique. Gastric bleeding eased
after the embolization and further stopped during the
hospitalization.
The 2-step method was successful in the remaining 11
patients (eight with chronic pancreatitis, one with pancre-
atic cancer, and two with acute pancreatitis). Six patients of
the eight patients with chronic pancreatitis, all without a
history of gastric bleeding, had gastric varices diagnosed
by CT scan, and one of them had hypersplenism; no gastric
bleeding was observed during the follow-up after the
embolization. The other four patients who underwent the
2-step method had gastric bleeding prior to the procedure,
and no gastric bleeding was found during the follow-up.
The patient with pancreatic cancer only received the first
step of the embolization, and was lost during the follow-up.
Adverse Events and Complications
Post-embolization syndrome, including abdominal pain in
the left upper quadrant area and fever, was the most fre-
quent complications observed during the follow-up. Pro-
phylactic antibiotics were used to prevent infections.
Analgesic antipyretics such as diclofenac sodium suppos-
itory and tramadol were used to control fever and
abdominal pain. Infection occurred in one patient after the
1-step embolization, perhaps caused by spleen necrosis as
indicated by CT scan; the platelet count was significantly
increased compared with the preoperative level in this
patient. For three patients with elevated platelet count
([904 9 109/L, even up to 1372 9 109/L in a patient),
aspirin was administrated to prevent thrombosis-related
Fig. 1 The spleen was embolized with the two-step technique in a
representative patient with gastric variceal bleeding caused by chronic
pancreatitis. A Collateral veins (arrow heads) in the stomach fundus
drains from splenic vein and the coronary vein (arrow). B Angiogram
of the splenic artery before the second embolic therapy showed the
residual spleen stain. C Angiogram of the splenic artery after total
embolization of splenic artery. D Atrophied spleen (arrow) 6 months
after splenic arterial embolization
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complications and disseminated intravascular coagulation.
Constipation occurred in five patients and was relieved
after the administration of laxatives. Severe complications
such as splenic abscess and rupture of spleen did not occur
in any of the patients.
Follow-Up Outcomes
The patients with acute gastric variceal bleeding received
enhanced CT scan in a month after embolization. Gastric
varices and collateral circulations reduced obviously in the
scan. In the second CT scan four months after the
embolization, the gastric varices and collateral circulations
had disappeared completely. During the follow-up, there
was no recurrence of gastric bleeding.
For the patients treated with 2-step method, the gastric
varices and collateral circulations reduced in the enhanced
CT scan after the first embolization. The patients did not
have gastric bleeding before the next embolization. After
the second embolization, the gastric varices and collateral
circulations disappeared gradually in the CT scans. There
was no gastric hemorrhage during the follow-up. One
patient with pancreatic cancer was lost during the follow-
up.
Discussion
In this retrospective study, we reported our experience
implementing partial splenic embolization combined with
splenic arterial embolization for SPH patients, in a 2-step
protocol. Symptomatic patients with upper tract hemor-
rhage who received the procedure did not experience any
relapse in gastric bleeding during the follow-up. Moreover,
the gastric varices of all the patients disappeared gradually
during the follow-up, as shown by CT scans. Procedure-
related complications included fever and abdominal pain,
which were tolerated by the patients. These results indi-
cated that partial splenic embolization combined with
splenic arterial embolization may be an effective and safe
treatment strategy for patients with SPH.
Splenic vein occlusion caused by splenic vein throm-
bosis or compression from surrounding tissues has been
recognized as the pathophysiological basis of SPH [2, 4, 5,
12]. Gastric variceal bleeding is one of the most serious
complications of SPH and may be life-threatening [1, 13,
14]. Splenectomy has been proposed as treatment for SPH,
because blood reflow to the varicose veins from the splenic
vein is completely eliminated after removal of the spleen
[8, 9, 15]. Normal circulation of the splenic vein can be
reestablished with a stent implanted in the splenic vein
through the thrombosis [16], but the patients should be
selected strictly and most patients are not suitable for
recanalization. Transjugular portosystemic shunt is not
indicated for SPH because the shunt does not decrease the
venous pressure in the gastric bundus. Splenic arterial
embolization and partial splenic embolization have each
been reported effective for the treatment of acute gastric
bleeding due to SPH [14, 17, 18].
We developed splenic arterial embolization and partial
splenic embolization to reduce variceal shunts around the
stomach as much as possible. Partial splenic embolization
is effective for the treatment of splenomegaly and hyper-
splenism, but these patients may suffer from serve post-
operative reactions such as splenic abscess, sepsis, and
rupture, due to the increased embolized spleen volume [10,
19–21]. According to published data and our clinical
experience, the volume of spleen infarction should be
controlled at 60–70 %. This not only relieves hyper-
splenism and gastric bleeding, but also decreases the
incidence of serious complications. The splenic function
returned after splenectomy for trauma and patients had low
incidence of infection [22]. Splenic immune function was
preserved in the patients after total or partial SAE for the
blunt splenic injury [23]. The life-threatening infection in
after SAE was relative rare with the covering use of pro-
phylactic antibiotics. Routine vaccination was not indicted
because the patients had normal splenic function after
splenic artery embolization for trauma [24]. The embolic
therapy discussed herein is minimally invasive, is of low
risk, and is well tolerated by patients. In this study, the two
embolic methods were applied according to the symptoms
and signs of bleeding. Patients with acute gastric variceal
bleeding were treated with the 1-step embolization, in
which the spleen and splenic artery were embolized at the
same session. For patients with chronic gastric variceal
bleeding, or without a history of gastric bleeding but with
gastric varices, the 2-step embolic method was performed,
firstly, to achieve splenic infarction of up to 60–70 %.
Splenic arterial embolization with coils decreases blood to
the spleen parenchyma. Furthermore, this method decrea-
ses the risk of pseudoaneurysm [25]. The 2-step method is
especially suitable for patients with splenomegaly and
hypersplenism. Consistent with the literatures, abdominal
pain and fever associated with post-embolization were the
main clinical complications. These clinical manifestations
may last for 3–10 days. For the patients treated with the
2-step method, less fever and abdominal pain may occur
compared with those who receive the 1-step procedure.
Prophylactic antibiotics and analgesic antipyretics may be
applied. Severe complications, such as splenic abscess and
rupture of the spleen, did not occur in these patients.
During the follow-up, the symptomatic patients did not
have upper gastric bleeding after the procedure. However,
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it is controversial whether SPH patients without gastric
bleeding require a splenectomy to cut off the blood flow
to the gastric varices. Madsen et al. [4] in 1986 reported a
high incidence of gastric bleeding (72 %) in SPH patients,
and others reported similarly. Butler et al. [1] found that
the incidence of splenic vein thrombosis caused by pan-
creatitis was 14.1 %, and the rate of gastric bleeding was
12.3 %. Sakorafas et al. [7] reported SPH diagnosed in 34
of 484 patients (7 %) with chronic pancreatitis. One of
the asymptomatic patients with lateral pancreatojejunos-
tomy and without splenectomy died due to gastric
bleeding after three years. Heider et al. [6] in 2004 found
that gastric bleeding occurred in 4 % of patients with
gastric varices during the follow-up and splenectomy was
needed in two patients. These data show that the inci-
dence of gastric bleeding has decreased in SPH patients
during the past decades, although the reasons are not
clear.
It has to be mentioned that our study constitutes our pri-
mary experience of a limited number of cases, and more
clinical evidence is needed. Moreover, in our study, the
diagnosis of SPH was based on imaging technology including
CT, magnetic resonance, and endoscopy. Recently, endo-
scopic ultrasound has been reported to be more sensitive in
detecting paraesophageal varices and gastric varices than
magnetic resonance or CT. Contrast-enhanced CT is also
widely used in the diagnosis of splanchnic vein thrombosis.
Future studies using these highly sensitive methods of
examination during diagnosis and the follow-up of SPH
patients are needed to confirm our results.
In conclusion, partial splenic embolization combined
with splenic arterial embolization was an effective and safe
treatment strategy for patients with SPH in this study.
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